HSBC Holdings’s Abivax ABVX Stock Holding History

HSBC Holdings’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.71M	Buy	15,426 +11,887	+336%	+$1.41M	﹤0.01%	1604
2025 Q4	$462K	Buy	+3,539	New	+$386K	﹤0.01%	2357

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

HSBC Holdings's ABVX Position: Q1 2026 in Review

HSBC Holdings increased its Abivax (ABVX) stake by 336% in Q1 2026, buying an estimated $1.41M and bringing the position to 15,426 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

HSBC Holdings first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

HSBC Holdings held 15,426 shares of Abivax worth $1.71M as of Q1 2026.
HSBC Holdings bought 11,887 Abivax shares in Q1 2026, an estimated $1.41M.
Abivax made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1604 holding.
HSBC Holdings first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.